A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- D3 Bio (Wuxi) Co., Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT07093398
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
- Conditions
- Type1diabetes
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Henan University of Science and Technology
- Target Recruit Count
- 36
- Registration Number
- NCT07092761
- Locations
- 🇨🇳
Henan University of Science and Technology, Luoyang, Henan, China
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model
- Conditions
- Substance UseHealthy
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 294
- Registration Number
- NCT07094061
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
- Conditions
- Heart Failure With Preserved Ejection FractionCoronary Microvascular Dysfunction
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 25
- Registration Number
- NCT07093528
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Comparative Effects of Kegel Versus Clamshell Exercises on Low Back Pain in Women With Uterine Fibroids: A Randomized Clinical Trial
- Conditions
- Low Back PainUterine Fibroids (UF)
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- University of Faisalabad
- Target Recruit Count
- 30
- Registration Number
- NCT07094633
- Locations
- 🇵🇰
The University of Faisalabad, Faisalābad, Pakistan
Combination iSTAT/Alinity and IR Oculography for Head CT Necessity and Recovery Prediction After mTBI
- Conditions
- Blood
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Captain James A. Lovell Federal Health Care Center
- Target Recruit Count
- 75
- Registration Number
- NCT07094230
- Locations
- 🇺🇸
Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois, United States
A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT07092748
- Locations
- 🇨🇳
Zhejiang Cancer hospital, Hangzhou, Zhejiang, China
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
- Conditions
- Multiple Myeloma RefractoryRelapsed Multiple Myeloma
- Interventions
- Drug: Target trough IgG level of 8-10 g/LDrug: Target trough IgG level 4-6 g/LDrug: No history of recurrent or severe infections and total IgG level higher or equal at 4 g/L
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- CHU de Quebec-Universite Laval
- Target Recruit Count
- 80
- Registration Number
- NCT07094048
- Locations
- 🇨🇦
Centre Intégré de Cancérologie, Québec, Quebec, Canada
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
- Conditions
- Paroxysmal Atrial Fibrillation (PAF)
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Target Recruit Count
- 344
- Registration Number
- NCT07092774
- Locations
- 🇺🇸
Arrhythmia Institute at Grandview, Birmingham, Alabama, United States
🇺🇸Community Memorial Hospital, Ventura, California, United States
🇺🇸Ascension St. Vincent's, Jacksonville, Florida, United States
A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212
- Conditions
- Acute Bronchitis
- Interventions
- Drug: DW5121Drug: DW51211Drug: DW51212
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 273
- Registration Number
- NCT07093697
- Locations
- 🇰🇷
Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
🇰🇷Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea, Republic of
🇰🇷Yeungnam University Medical Center, Daegu, Korea, Republic of